FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Christos Apostolidis

Research Profile

Chemicals & Drugs

Objects

Alpha Particles

Procedures

Radioimmunotherapy

Living Beings

Anatomy

Concepts & Ideas

Disorders

Neoplasm Metastasis

Devices

Radiometry

Co-author Network

Publications

TOP 3
Damien Hudry; Christian Kübel; Christos Apostolidis; Eglantine Courtois; Thomas Gouder; Olaf Walter; Daniel Meyer
Controlled synthesis of thorium and uranium oxide nanocrystals.
M Marouli; R Van Ammel; Christos Apostolidis; Frank Bruchertseifer; H Dikmen; A Dirican; V Jobbágy; J Paepen; S Pommé; H Stroh; G Suliman; A Morgenstern
Decay data measurements on 213Bi using recoil atoms.
Christos Apostolidis; Olaf Walter
catena-Poly[[tris-(acetonitrile-κN)praseodymium(III)]tris-(μ-trifluoro-methane-sulfonato-κ(2) O:O')].

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Christos Apostolidis (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Damien Hudry; Christian Kübel; Christos Apostolidis; Eglantine Courtois; Thomas Gouder; Olaf Walter; Daniel Meyer
Controlled synthesis of thorium and uranium oxide nanocrystals.
Chemistry (Weinheim an der Bergstrasse, Germany) 2013;19(17):5297-305.
2013: M Marouli; R Van Ammel; Christos Apostolidis; Frank Bruchertseifer; H Dikmen; A Dirican; V Jobbágy; J Paepen; S Pommé; H Stroh; G Suliman; A Morgenstern
Decay data measurements on 213Bi using recoil atoms.
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 2013;74():123-7.
2013: Christos Apostolidis; Olaf Walter
catena-Poly[[tris-(acetonitrile-κN)praseodymium(III)]tris-(μ-trifluoro-methane-sulfonato-κ(2) O:O')].
Acta crystallographica. Section E, Structure reports online 2013;69(Pt 1):m21.
2012: S Pommé; H Stroh; G Suliman; R Van Ammel; Christos Apostolidis; Frank Bruchertseifer; H Dikmen; A Dirican; V Jobbágy; M Marouli; J Paepen; A Morgenstern
Measurement of the 225Ac half-life.
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 2012;70(11):2608-14.
2012: S Pommé; H Stroh; G Suliman; R Van Ammel; K Abbas; T Altzitzoglou; Christos Apostolidis; V Jobbágy; M Marouli; J Paepen; A Morgenstern
Measurement of the 230U half-life.
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 2012;70(9):1900-6.
2012: S Pommé; H Stroh; G Suliman; R Van Ammel; K Abbas; Christos Apostolidis; V Jobbágy; M Marouli; J Paepen; A Morgenstern
Measurement of the 226Th and 222Ra half-lives.
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 2012;70(9):1913-8.
2012: G Suliman; R Van Ammel; J Paepen; S Pommé; H Stroh; K Abbas; Christos Apostolidis; V Jobbágy; M Marouli; A Morgenstern
Measurements of the half-life of 214Po and 218Rn using digital electronics.
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 2012;70(9):1907-12.
2012: M Marouli; K Abbas; Christos Apostolidis; A Dirican; V Jobbágy; J Paepen; S Pommé; H Stroh; G Suliman; R Van Ammel; A Morgenstern
High-resolution alpha-particle spectrometry of the 230U decay series.
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 2012;70(9):2270-4.
2012: Damien Hudry; Christian Kübel; Christos Apostolidis; Eglantine Courtois; Thomas Gouder; Olaf Walter; Daniel Meyer
Non-aqueous synthesis of isotropic and anisotropic actinide oxide nanocrystals.
Chemistry (Weinheim an der Bergstrasse, Germany) 2012;18(27):8283-7.
2012: Alfred Morgenstern; Frank Bruchertseifer; Christos Apostolidis
Bismuth-213 and actinium-225 -- generator performance and evolving therapeutic applications of two generator-derived alpha-emitting radioisotopes.
Current radiopharmaceuticals 2012;5(3):221-7.
2012: Sma Rizvi; Cs Lee; Alfred Morgenstern; Bj Allen; Christos Apostolidis; Frank Bruchertseifer; Ra Clarke
Orthotopic administration of (213)Bi-bevacizumab inhibits progression of PC3 xenografts in the prostate.
Immunotherapy 2012;4(5):549-54.
2011: Barry J Allen; Christos Apostolidis; Frank Bruchertseifer; Peter Graham; Syed M Abbas Rizvi; Apresh A Singla; Alfred Morgenstern
Analysis of patient survival in a Phase I trial of systemic targeted α-therapy for metastatic melanoma.
Immunotherapy 2011;3(9):1041-50.
2010: Christos Apostolidis; Bernd Schimmelpfennig; Nicola Magnani; Patric Lindqvist-Reis; Olaf Walter; Richard Sykora; Alfred Morgenstern; Eric Colineau; Roberto Caciuffo; Reinhardt Klenze; Richard G Haire; Jean Rebizant; Frank Bruchertseifer; Thomas Fanghänel
[An(H2O)9](CF3SO3)3 (An=U-Cm, Cf): exploring their stability, structural chemistry, and magnetic behavior by experiment and theory.
Angewandte Chemie (International ed. in English) 2010;49(36):6343-7.
2010: Gilles Montavon; Urska Repinc; Christos Apostolidis; Frank Bruchertseifer; Kamel Abbas; Alfred Morgenstern
Investigation of para-sulfonatocalix[n]arenes [n = 6, 8] as potential chelates for (230)U.
Dalton transactions (Cambridge, England : 2003) 2010;39(5):1366-74.
2010: Christof Seidl; Matthias Port; Christos Apostolidis; Frank Bruchertseifer; Markus Schwaiger; Reingard Senekowitsch-Schmidtke; Michael Abend
Differential gene expression triggered by highly cytotoxic alpha-emitter-immunoconjugates in gastric cancer cells.
Investigational new drugs 2010;28(1):49-60.
2009: Gilles Montavon; Christos Apostolidis; Frank Bruchertseifer; Urska Repinc; Alfred Morgenstern
Spectroscopic study of the interaction of U(VI) with transferrin and albumin for speciation of U(VI) under blood serum conditions.
Journal of inorganic biochemistry 2009;103(12):1609-16.
2008: Alfred Morgenstern; Christos Apostolidis; Frank Bruchertseifer; Roberto Capote; Thomas Gouder; Federica Simonelli; Mihaela Sin; Kamel Abbas
Cross-sections of the reaction 232Th(p,3n)230Pa for production of 230U for targeted alpha therapy.
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 2008;66(10):1275-80.
2008: Emma Y Song; Syed M A Rizvi; Chang F Qu; Chand Raja; Johnson Yuen; Yong Li; Alfred Morgenstern; Christos Apostolidis; Barry J Allen
The cytokinesis-block micronucleus assay as a biological dosimeter for targeted alpha therapy.
Physics in medicine and biology 2008;53(2):319-28.
2008: Emma Y Song; Chang F Qu; Syed M A Rizvi; Chand Raja; Julia Beretov; Alfred Morgenstern; Christos Apostolidis; Frank Bruchertseifer; Alan Perkins; Barry J Allen
Bismuth-213 radioimmunotherapy with C595 anti-MUC1 monoclonal antibody in an ovarian cancer ascites model.
Cancer biology & therapy 2008;7(1):76-80.
2007: Emma Y Song; Syed M Abbas Rizvi; Chang F Qu; Chand Raja; Martin W Brechbiel; Alfred Morgenstern; Christos Apostolidis; Barry J Allen
Pharmacokinetics and toxicity of (213)Bi-labeled PAI2 in preclinical targeted alpha therapy for cancer.
Cancer biology & therapy 2007;6(6):898-904.
2007: Chand Raja; Peter Graham; Syed M Abbas Rizvi; Emma Song; Helen Goldsmith; John Thompson; Anja Bosserhoff; Alfred Morgenstern; Christos Apostolidis; John Kearsley; Ralph A Reisfeld; Barry J Allen
Interim analysis of toxicity and response in phase 1 trial of systemic targeted alpha therapy for metastatic melanoma.
Cancer biology & therapy 2007;6(6):846-52.
2007: H Matthias Buchhorn; Christof Seidl; Roswitha Beck; Dieter Saur; Christos Apostolidis; Alfred Morgenstern; Markus Schwaiger; Reingard Senekowitsch-Schmidtke
Non-invasive visualisation of the development of peritoneal carcinomatosis and tumour regression after 213Bi-radioimmunotherapy using bioluminescence imaging.
European journal of nuclear medicine and molecular imaging 2007;34(6):841-9.
2007: Claudia Friesen; Gerhard Glatting; Bernd Koop; Klaus Schwarz; Alfred Morgenstern; Christos Apostolidis; Klaus-Michael Debatin; Sven N Reske
Breaking chemoresistance and radioresistance with [213Bi]anti-CD45 antibodies in leukemia cells.
Cancer research 2007;67(5):1950-8.
2007: Patric Lindqvist-Reis; Christos Apostolidis; Jean Rebizant; Alfred Morgenstern; Reinhardt Klenze; Olaf Walter; Thomas Fanghänel; Richard G Haire
The structures and optical spectra of hydrated transplutonium ions in the solid state and in solution.
Angewandte Chemie (International ed. in English) 2007;46(6):919-22.
2006: Jian Wang; Syed M Abbas Rizvi; Michele C Madigan; Paul J Cozzi; Carl A Power; Chang F Qu; Alfred Morgenstern; Christos Apostolidis; Pamela J Russell; Barry J Allen; Yong Li
Control of prostate cancer spheroid growth using 213Bi-labeled multiple targeted alpha radioimmunoconjugates.
The Prostate 2006;66(16):1753-67.
2006: Ekaterina Dadachova; Mahesh C Patel; Sima Toussi; Christos Apostolidis; Alfred Morgenstern; Martin W Brechbiel; Miroslaw K Gorny; Susan Zolla-Pazner; Arturo Casadevall; Harris Goldstein
Targeted killing of virally infected cells by radiolabeled antibodies to viral proteins.
PLoS medicine 2006;3(11):e427.
2006: Katia Vandenbulcke; Hubert Thierens; Filip De Vos; Jan Philippé; Fritz Offner; Ann Janssens; Christos Apostolidis; Alfred Morgenstern; Klaus Bacher; Virginie de Gelder; Rudi A Dierckx; Guido Slegers
In vitro screening for synergism of high-linear energy transfer 213Bi-radiotherapy with other therapeutic agents for the treatment of B-cell chronic lymphocytic leukemia.
Cancer biotherapy & radiopharmaceuticals 2006;21(4):364-72.
2006: Luis R Martinez; Ruth A Bryan; Christos Apostolidis; Alfred Morgenstern; Arturo Casadevall; Ekaterina Dadachova
Antibody-guided alpha radiation effectively damages fungal biofilms.
Antimicrobial agents and chemotherapy 2006;50(6):2132-6.
2006: Ekaterina Dadachova; Ruth A Bryan; Christos Apostolidis; Alfred Morgenstern; Tong Zhang; Tiffany Moadel; Marcela Torres; Xianchun Huang; Ekaterina Revskaya; Arturo Casadevall
Interaction of radiolabeled antibodies with fungal cells and components of the immune system in vitro and during radioimmunotherapy for experimental fungal infection.
The Journal of infectious diseases 2006;193(10):1427-36.
2006: Syed M Abbas Rizvi; Yong Li; Emma Y Song; Chang F Qu; Chand Raja; Alfred Morgenstern; Christos Apostolidis; Barry J Allen
Preclinical studies of bismuth-213 labeled plasminogen activator inhibitor type 2 (PAI2) in a prostate cancer nude mouse xenograft model.
Cancer biology & therapy 2006;5(4):386-93.
2006: Yan Jun Song; Chang F Qu; Syed M A Rizvi; Yong Li; G Robertson; Chand Raja; Alfred Morgenstern; Christos Apostolidis; Alan C Perkins; Barry J Allen
Cytotoxicity of PAI2, C595 and Herceptin vectors labeled with the alpha-emitting radioisotope Bismuth-213 for ovarian cancer cell monolayers and clusters.
Cancer letters 2006;234(2):176-83.
2005: Stéphane Supiot; Sébastien Gouard; Josiane Charrier; Christos Apostolidis; Jean-François Chatal; Jacques Barbet; François Davodeau; Michel Cherel
Mechanisms of cell sensitization to alpha radioimmunotherapy by doxorubicin or paclitaxel in multiple myeloma cell lines.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(19 Pt 2):7047s-7052s.
2005: Christos Apostolidis; Roger Molinet; G Rasmussen; Alfred Morgenstern
Production of Ac-225 from Th-229 for targeted alpha therapy.
Analytical chemistry 2005;77(19):6288-91.
2005: Christof Seidl; Hedwig Schröck; Sabine Seidenschwang; Roswitha Beck; Ernst Schmid; Michael Abend; Karl-Friedrich Becker; Christos Apostolidis; Tuomo K Nikula; Elisabeth Kremmer; Markus Schwaiger; Reingard Senekowitsch-Schmidtke
Cell death triggered by alpha-emitting 213Bi-immunoconjugates in HSC45-M2 gastric cancer cells is different from apoptotic cell death.
European journal of nuclear medicine and molecular imaging 2005;32(3):274-85.
2005: Christos Apostolidis; Roger Molinet; J McGinley; K Abbas; J Möllenbeck; Alfred Morgenstern
Cyclotron production of Ac-225 for targeted alpha therapy.
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 2005;62(3):383-7.
2005: Chang F Qu; Emma Y Song; Yong Li; Syed M A Rizvi; Chand Raja; Ross Smith; Alfred Morgenstern; Christos Apostolidis; Barry J Allen
Pre-clinical study of 213Bi labeled PAI2 for the control of micrometastatic pancreatic cancer.
Clinical & experimental metastasis 2005;22(7):575-86.
2004: Chang F Qu; Yong Li; Yan Jun Song; Syed M A Rizvi; Chand Raja; D Zhang; Jaswinder S Samra; Ross Smith; Alan C Perkins; Christos Apostolidis; Barry J Allen
MUC1 expression in primary and metastatic pancreatic cancer cells for in vitro treatment by (213)Bi-C595 radioimmunoconjugate.
British journal of cancer 2004;91(12):2086-93.
2004: Katia Vandenbulcke; Hubert Thierens; Fritz Offner; Ann Janssens; Virginie de Gelder; Klaus Bacher; Jan Philippé; Filip De Vos; Rudi Dierckx; Christos Apostolidis; Alfred Morgenstern; Guido Slegers
Importance of receptor density in alpha radioimmunotherapy in B cell malignancies: an in-vitro study.
Nuclear medicine communications 2004;25(11):1131-6.
2004: Ekaterina Dadachova; T Burns; Ruth A Bryan; Christos Apostolidis; M W Brechbiel; Joshua D Nosanchuk; Arturo Casadevall; Liise-anne Pirofski
Feasibility of radioimmunotherapy of experimental pneumococcal infection.
Antimicrobial agents and chemotherapy 2004;48(5):1624-9.
2004: Ekaterina Dadachova; Ruth A Bryan; Annie Frenkel; Tong Zhang; Christos Apostolidis; Jerome S Nosanchuk; Joshua D Nosanchuk; Arturo Casadevall
Evaluation of acute hematologic and long-term pulmonary toxicities of radioimmunotherapy of Cryptococcus neoformans infection in murine models.
Antimicrobial agents and chemotherapy 2004;48(3):1004-6.
2003: Katia Vandenbulcke; Filip De Vos; Fritz Offner; Jan Philippé; Christos Apostolidis; Roger Molinet; Tuomo K Nikula; Klaus Bacher; Virginie de Gelder; Anne Vral; Christophe Lahorte; Hubert Thierens; Rudi A Dierckx; Guido Slegers
In vitro evaluation of 213Bi-rituximab versus external gamma irradiation for the treatment of B-CLL patients: relative biological efficacy with respect to apoptosis induction and chromosomal damage.
European journal of nuclear medicine and molecular imaging 2003;30(10):1357-64.
2003: Roswitha Huber; Christof Seidl; Ernst Schmid; Sabine Seidenschwang; Karl-Friedrich Becker; Christoph Schuhmacher; Christos Apostolidis; Tuomo K Nikula; Elisabeth Kremmer; Markus Schwaiger; Reingard Senekowitsch-Schmidtke
Locoregional alpha-radioimmunotherapy of intraperitoneal tumor cell dissemination using a tumor-specific monoclonal antibody.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(10 Pt 2):3922S-8S.
2003: Miederer Matthias; Christof Seidl; Gerd-Jürgen Beyer; David E Charlton; Sanja Vranjes-Duric; Jozef J Comor; Roswitha Huber; Tuomo K Nikula; Christos Apostolidis; Christoph Schuhmacher; Karl-Friedrich Becker; Reingard Senekowitsch-Schmidtke
Comparison of the radiotoxicity of two alpha-particle-emitting immunoconjugates, terbium-149 and bismuth-213, directed against a tumor-specific, exon 9 deleted (d9) E-cadherin adhesion protein.
Radiation research 2003;159(5):612-20.
2002: Alfred Morgenstern; Christos Apostolidis; Klaus Mayer
Age determination of highly enriched uranium: separation and analysis of 231Pa.
Analytical chemistry 2002;74(21):5513-6.
2002: M Wallenius; Alfred Morgenstern; Christos Apostolidis; Klaus Mayer
Determination of the age of highly enriched uranium.
Analytical and bioanalytical chemistry 2002;374(3):379-84.
2001: Reingard Senekowitsch-Schmidtke; Christoph Schuhmacher; Karl-Friedrich Becker; Tuomo K Nikula; Christof Seidl; I Becker; Miederer Matthias; Christos Apostolidis; C Adam; Roswitha Huber; Elisabeth Kremmer; K Fischer; Markus Schwaiger
Highly specific tumor binding of a 213Bi-labeled monoclonal antibody against mutant E-cadherin suggests its usefulness for locoregional alpha-radioimmunotherapy of diffuse-type gastric cancer.
Cancer research 2001;61(7):2804-8.
1999: Olivier Couturier; Alain Faivre-Chauvet; IV Filippovich; Philippe Thédrez; Catherine Saï-Maurel; Manuel Bardiès; A K Mishra; M Gauvrit; G Blain; Christos Apostolidis; Roger Molinet; J C Abbe; Régis Bataille; John Wijdenes; Jean-François Chatal; Michel Chérel
Validation of 213Bi-alpha radioimmunotherapy for multiple myeloma.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10 Suppl):3165s-3170s.
1999: Thomas M Behr; George Sgouros; M G Stabin; Martin Béhé; Christa Angerstein; Rosalyn D Blumenthal; Christos Apostolidis; Roger Molinet; Robert M Sharkey; Lilli Koch; David M Goldenberg; Wolfgang Becker
Studies on the red marrow dosimetry in radioimmunotherapy: an experimental investigation of factors influencing the radiation-induced myelotoxicity in therapy with beta-, Auger/conversion electron-, or alpha-emitters.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10 Suppl):3031s-3043s.
1999: Thomas M Behr; Martin Béhé; M G Stabin; E Wehrmann; Christos Apostolidis; Roger Molinet; F Strutz; Afshin Fayyazi; E Wieland; Stefan Gratz; Lilli Koch; David M Goldenberg; Wolfgang Becker
High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
Cancer research 1999;59(11):2635-43.
1999: Tuomo K Nikula; Michael R McDevitt; Ronald D Finn; Chuanchu Wu; R W Kozak; Kayhan Garmestani; Martin W Brechbiel; Michael J Curcio; CG Pippin; L Tiffany-Jones; MW Geerlings; Christos Apostolidis; Roger Molinet; M W Geerlings; Otto A Gansow; David A Scheinberg
Alpha-emitting bismuth cyclohexylbenzyl DTPA constructs of recombinant humanized anti-CD33 antibodies: pharmacokinetics, bioactivity, toxicity and chemistry.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1999;40(1):166-76.
1995: F M Kaspersen; E Bos; A V Doornmalen; M W Geerlings; Christos Apostolidis; Roger Molinet
Cytotoxicity of 213Bi- and 225Ac-immunoconjugates.
Nuclear medicine communications 1995;16(6):468-76.
1993: M W Geerlings; F M Kaspersen; Christos Apostolidis; R van der Hout
The feasibility of 225Ac as a source of alpha-particles in radioimmunotherapy.
Nuclear medicine communications 1993;14(2):121-5.